MedPath

POCUS and Respiratory Failure Prognosis Based on Diaphragmatic Dysfunction

Not yet recruiting
Conditions
Respiratory Failure
Diaphragm Disease
Registration Number
NCT05869045
Lead Sponsor
Azienda Ospedaliero-Universitaria di Modena
Brief Summary

This study aims to evaluate the use of POCUS to assess diaphragmatic function and its association with clinical outcomes in patients with respiratory failure who are admitted to the emergency department.

Detailed Description

Respiratory failure is a common condition that requires prompt diagnosis and treatment in the emergency department. Diaphragmatic dysfunction (DD) is a potential contributor to respiratory failure, but it is often underdiagnosed and undertreated. Point-of-care ultrasound (POCUS) is a non-invasive and feasible tool that can measure diaphragmatic function using parameters such as diaphragm excursion and diaphragm shortening fraction (DSF). However, the prognostic value of POCUS for DD in patients with respiratory failure is unclear.

This study is a prospective observational cohort study that will enroll consecutive patients with respiratory failure who are admitted to the emergency department of a tertiary hospital. All patients will undergo POCUS examination of the diaphragm within 6 hours of admission by trained emergency physicians. The primary outcome will be the composite of mortality, intubation, or noninvasive ventilation failure within 30 days of admission. The secondary outcomes will include length of hospital stay, intensive care unit admission, and ventilator-free days. The association between POCUS parameters of diaphragmatic function and clinical outcomes will be analyzed using multivariate logistic regression and Cox proportional hazards models.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
432
Inclusion Criteria
  • Respiratory failure defined as one or more of the following: respiratory rate >24 breaths/min, oxygen saturation <90% on room air, PaO2/FiO2 ratio <300 mmHg, or need for supplemental oxygen
  • Ability to provide informed consent or availability of a legal representative
Exclusion Criteria
  • Pregnancy
  • History of thoracic surgery or trauma
  • Known neuromuscular disease affecting the diaphragm
  • Contraindications for POCUS examination such as chest wall deformity, subcutaneous emphysema, or skin infection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite of mortality, intubation, or noninvasive ventilation failure within 30 days of admissionPatients will be followed up for a maximum of 1 months from admission to the emergency department, until discharge or death
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.